Department of Gynecology, Nanjing Medical University, Affiliated Hangzhou Hospital (Hangzhou First People's Hospital), Hangzhou, Zhejiang 310006, P.R. China.
Mol Med Rep. 2017 Sep;16(3):2875-2880. doi: 10.3892/mmr.2017.6857. Epub 2017 Jun 27.
Our previous demonstrated that macrophage colony‑stimulating factor (M‑CSF) stimulated the production of estradiol (E2) and progesterone (P) in luteinized granulosa cells (GCs), and that its secretion may be regulated by follicle‑stimulating hormone (FSH). The present study aimed to examine the effect of M‑CSF alone or with Letrozole treatment on the function of non‑luteinizing granulosa cells, using the COV434 cell line, and its interaction with FSH. Human luteinized granulosa cells (LGC) were isolated from the follicular fluid of superovulated infertile patients (average age, 30.8±2.1 years) undergoing an intracytoplasmic sperm injection. The LGC were cultured with various concentrations of recombinant human macrophage colony stimulating factor (rhM‑CSF; 0, 10, 25, 50 or 100 ng/ml), rhM‑CSF+Letrozole (10‑6 mol/l), rhFSH (0, 10, 25, 50 or 100 IU/ml), or rhFSH+Letrozole (10‑6 mol/l). E2 concentrations in the media were measured using ELISA. The expression levels of the FSH receptor and the M‑CSF receptor were detected via reverse transcription‑quantitative polymerase chain reaction. Following COV434 cell treatment with M‑CSF, cell proliferation was quantified using the MTS assay and protein expression was detected by western blotting. It was demonstrated that M‑CSF and FSH stimulated the production of E2. The production of FSH receptors was enhanced by rhM‑CSF or rhM‑CSF+Letrozole in vitro in a dose‑dependent manner. It was observed that rhFSH promoted the expression of the M‑CSF receptor, at a certain concentration. Proliferation of COV434 cells increased in a dose‑dependent manner following treatment with RhM‑CSF. Furthermore, M‑CSF induced the phosphorylation of c‑Jun N‑terminal kinase (JNK) and p38; however, the level of E2 in the medium was not altered when the cells were pretreated with the JNK inhibitor SP600125 or the p38 inhibitor SB203580. The present study suggested that M‑CSF may be important in regulating the response of GCs to gonadotropin and may have a promotive effect in the early phase of follicular development. The biological effects of M‑CSF may partially be attributed to activation of the JNK and p38 signaling pathways. M‑CSF may represent a novel follicular development regulator agent in the future.
我们之前的研究表明,巨噬细胞集落刺激因子(M-CSF)可刺激黄体化颗粒细胞(GC)产生雌二醇(E2)和孕酮(P),其分泌可能受卵泡刺激素(FSH)调节。本研究旨在使用 COV434 细胞系,研究 M-CSF 单独或与来曲唑治疗对非黄体化颗粒细胞功能的影响,及其与 FSH 的相互作用。从接受胞浆内精子注射的超排卵不孕患者(平均年龄 30.8±2.1 岁)的卵泡液中分离人黄体化 GC,并用不同浓度的重组人巨噬细胞集落刺激因子(rhM-CSF;0、10、25、50 或 100ng/ml)、rhM-CSF+来曲唑(10-6mol/L)、rhFSH(0、10、25、50 或 100IU/ml)或 rhFSH+来曲唑(10-6mol/L)培养。采用 ELISA 法检测培养基中 E2 浓度。采用逆转录定量聚合酶链反应检测 FSH 受体和 M-CSF 受体的表达水平。用 MTS 法检测 COV434 细胞经 M-CSF 处理后的增殖情况,用 Western blot 法检测蛋白表达。结果表明,M-CSF 和 FSH 均可刺激 E2 的产生。rhM-CSF 或 rhM-CSF+来曲唑可体外剂量依赖性增强 FSH 受体的产生。结果发现,rhFSH 可在一定浓度下促进 M-CSF 受体的表达。用 RhM-CSF 处理后,COV434 细胞的增殖呈剂量依赖性增加。此外,M-CSF 诱导 c-Jun N-末端激酶(JNK)和 p38 的磷酸化;然而,当细胞用 JNK 抑制剂 SP600125 或 p38 抑制剂 SB203580 预处理时,培养基中 E2 的水平并未改变。本研究表明,M-CSF 可能在调节 GC 对促性腺激素的反应中起重要作用,并可能在卵泡发育的早期阶段具有促进作用。M-CSF 的生物学效应可能部分归因于 JNK 和 p38 信号通路的激活。M-CSF 可能成为未来一种新的卵泡发育调节剂。